期刊
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY
卷 10, 期 7, 页码 915-919出版社
INFORMA HEALTHCARE
DOI: 10.1517/17425255.2014.922954
关键词
big data; biomarkers; cardiovascular; diagnosis; epidemiology; metabolomics; metabonomics; mass spectrometry; NMR; oncology; phenotyping; prognosis; surgery
The role that metabolic phenotyping can increasingly play in patient stratification and personalised medicine is discussed. The background to the general approach, comprehensive and simultaneous analysis of small-molecule metabolites in biofluids, tissues and tissue extracts combined with suitable multivariate statistical models, is summarised. The main techniques used (NMR and mass spectrometry) are cited, and the implementation of dedicated phenome centres is explained. Finally, the advantages and limitations, opportunities and drawbacks of the approach are discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据